Recommendations to the patient.: Recommendations to the patient
Study summary
Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.
This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.
Eligibility
Sex
ALL
Min age
40 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Age between 40 and 75 years
* hypertension
* hyperglycaemia
* type 2 diabetes not requiring insulin therapy
* dyslipidaemia
* active smoking
* overweight/grade I obesity
* Willingness to participate in follow-up visits over 24 months
Exclusion Criteria:
* previous myocardial infarction
* stroke
* transient ischemic attack
* coronary artery diseas
* peripheral arterial occlusive disease
* heart failure
* Type 1 or type 2 diabetes mellitus on insulin therapy
* Advanced chronic kidney disease (eGFR \< 30 mL/min/1.73 m²)
* Active cancer disease
* Severe obesity
* Inability to use digital tools
* Pregnancy
Primary outcome measure(s)
Blood pressure — 12 months Systolic and diastolic in millimeters of mercury
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.